The presence of pTau in the brains of HD patients was first recognized over 40 years ago, and continued research has revealed the presence of different Tau isoforms in early and late-onset HD, with a total of around 60% of patients showing Tau pathology [85]. The gene discussed is MAPT; the disease is Huntington disease.